Please assess the completion status of the following clinical trial:

Trial Title: Detection of PPROM With AmniSure PAMG-1 Rapid Immunoassay

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* women presenting to assessment at the labour and delivery unit at RUH with suspected PPROM between 16+0 and 36+6 weeks gestation~* consent to enrollment~Exclusion Criteria:~* vaginal bleeding~* active labor (cervical dilation \> 2 cm or effacement \> 80%)~* multiple pregnancy~* fetal anomalies~* placenta previa~* fluid loss per vagina \> 7 days~* prior inclusion in the study

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PPROM (Type: None): All women presenting to assessment at the labour and delivery unit at RUH with suspected PPROM between 16+0 and 36+6 weeks gestation.

Based on this trial design, predict the completion outcome and termination type (if applicable).